The vast majority of genetic variants associated with complex human traits map to non-coding regions, but little is understood about how they modulate gene regulation in health and disease.
The vast majority of disease-associated loci identified through genome-wide association studies (GWAS) (1-3) are located in non-coding regions of the genome, often distant from the nearest gene (4) , suggesting that abnormalities in transcriptional regulation are a key driver of human disease. Quantitative trait loci (QTL) studies that map genetic variants associated with molecular traits provide a framework for interpreting the regulatory and functional role of diseaseassociated loci. For example, thousands of non-coding variants associated with gene expression (expression QTLs -eQTLs), a significant number of which overlap GWAS loci, have been identified in diverse cell types and tissues (5) , including in resting (6) (7) (8) and in stimulated (9, 10) immune cells. However, because of linkage disequilibrium and the complex regulation of gene expression, it remains difficult to pinpoint the causal genetic variant and to determine the mechanistic basis for most eQTLs.
Genetic analysis of chromatin organization (11) (12) (13) (14) (15) provides a powerful complementary approach for identifying genetic variants that affect transcriptional regulation in cis-regulatory regions (16) . In lymphoblastoid cell lines, many genetic variants have been associated with variability in DNase I hypersensitivity (measured by DNase-seq) (17) or histone tail modifications (measured by ChIP-seq) (18) (19) (20) . However, both DNase-seq and ChIP-seq are laborious and require large numbers of cells, thus limiting genetic studies using these techniques to cell lines. The recent development of Assay for Transposase-Accessible Chromatin (ATACseq), a simple yet efficient two-step protocol (21) , has opened the way to profiling of chromatin accessibility with small numbers of disease-relevant primary cells isolated from a large human cohort.
Here, we studied the genetic determinants of chromatin accessibility by performing ATAC-seq on primary CD4 + T cells isolated from 105 healthy donors of European descent in the ImmVar Consortium (10) (Fig. 1A) . To this end, we developed an optimized ATAC-seq protocol (SOM) that achieved high technical and biological reproducibility ( fig. S2) , highly complex libraries (on average 84% usable nuclear reads, as opposed to 40% prior to optimization) ( fig. S1 ) and low mitochrondrial DNA (mtDNA) contamination (on average contamination < 3%, as opposed to 53% prior to optimization).
We first assayed CD4 + T cells (T helper, Th) in two different states: either unstimulated, or activated in vitro using anti-CD3 and anti-CD28 antibodies for 48 hours (Fig. 1A) to assess global changes in chromatin accessibility after in vitro activation. Comparing pooled reads across six samples (five donors, one of which is replicated) in each state (stimulated or unstimulated), we observed a global increase in chromatin accessibility after activation, detecting 36 ,486 chromatin accessibility peaks (ATAC-peaks) in unstimulated cells and 52,154 ATACpeaks in activated cells. Of the 63,763 ATAC-peaks identified in at least one of the two states, 27 ,446 were shared across states, 28,017 were more accessible in activated cells (FDR, q < 0.05), but only 8,298 ATAC-peaks were more accessible in unstimulated cells (FDR, q < 0.05) ( Fig.   1B and table S1 ). Activation-specific ATAC-peaks were enriched at enhancers associated with conventional T helper cells (T conv , a class that includes Th1, and Th17 cells) (16) and depleted at enhancers associated with regulatory T cells (T reg ) and naïve Th cells. They were also enriched in stimulated Th cells and Th0 cells, consistent with our stimulation protocol (Fig. 1C) .
Similarly, activation-specific ATAC-peaks were enriched for motifs binding transcription factors (TFs) that are important for Th cell activation, including BATF, IRF and AP1 (22) (23) (24) (Fig. 1D) .
In particular, 1,594 of the 9,724 activation-specific ATAC-peaks located in noncoding regions previously unannotated by H3K27Ac overlapped BATF motifs (16%) ( fig. S3 ). TF footprints derived from normalized ATAC-seq reads that span known TF binding sites from ChIP-seq data (25) showed increased accessibility of BATF, ISRE and BATF/IRF motifs in stimulated cells, consistent with the known role of these factors in Th cell development and activation (22) (23) (24) ( Fig. 1E) . In contrast, CTCF and ETS binding motifs were enriched at shared ATAC-peaks showing little change in accessibility following activation ( Fig. 1D and 1E) . This is consistent with the known role of ETS family transcription factors as pioneer factors that establish the chromatin landscape for T cells (26) (27) (28) . Finally, single nucleotide polymorphisms (SNPs) associated with several autoimmune diseases (most notably inflammatory bowel disease (IBD)) were more enriched in activation-specific and shared ATAC-peaks than in baseline-specific peaks ( Fig. 1F) . These results demonstrate the power of ATAC-seq to identify previously unannotated cis-regulatory elements and generate high-resolution TF footprints, providing insights into the regulation of Th cell function and its role in underlying disease mechanisms.
Next, we explored higher order relationships in our ATAC-Seq data using the 105 profiles from activated T cells. We found 1,762 pairs of ATAC-peaks with highly correlated accessibility (linear regression, FDR < 0.05, table S2, fig. S4 ), corresponding to 851 (1.6%) distinct ATACpeaks of the 52,154 total ATAC-peaks we observed in activated T cells. On average, correlated peaks were located 313 kb apart, with the closest located only 668 bp apart. The large average distance between correlated peaks suggests that the correlation is unlikely to be the result of local biases in sequencing depth ( fig. S5 ).
Next, we characterized the genetic basis of chromatin accessibility in activated T cells by comparing the variability in ATAC-peaks across the 105 individuals with the imputed genotypes of ~10 million SNPs in those individuals (SOM). We found 1,790 ATAC-peaks associated with at least one significant local (+/-20kb) SNP (RASQUAL (29), P < 3.02×10 -4 , permutation FDR < 0.1) ( Fig. 2A, table S3 ). We term each such associated SNP an ATAC quantitative trait locus (ATAC-QTL) and the corresponding peak an ATAC-QTL-peak. Of the 1,790 ATAC-QTLpeaks, 599 were significantly heritable (GCTA FDR < 0.1) with an average heritability h 2 = 60%. In 580 (97%) of those cases, 36% of the heritability was predicted by the best lead SNP ( Fig. 2B, SOM, table S9 ), suggesting that the heritable variability of ATAC-QTL-peaks is largely determined by a single SNP. There were also 6,154 ATAC-QTL-peaks (RASQUAL, P < 3.02×10 -4 , permutation FDR < 0.1) with distal associations to SNPs located between +/-20 kb and +/-500 kb away, but only 2,634 ATAC-QTL-peaks (linear regression, P < 6.46×10 -5 , permutation FDR < 0.05) with distal associations to SNPs located over 500 kb away. This is consistent with previous observations of limited distal associations to chromatin accessibility traits estimated using DNase I hypersensitivity (17, 18) .
Several lines of evidence support a model where local ATAC-QTLs disrupt cis-regulatory functions in Th cell enhancers. First, of the 1,790 local ATAC-QTL-peaks, 33% (589) of the lead associated SNPs were located within 2 kb of the ATAC-peak and 18% (327) were located within the ATAC-peak width proper ( Fig. 2C) , suggesting that the direct disruption of cis-regulatory elements may be an important determinant of the observed variation in accessibility in those cases. Second, local ATAC-QTLs-peaks were more enriched near transcription start sites (TSS) than transcription termination sites (TTS) of the closest gene, supporting a transcriptional role in cis ( Fig. 2D) . Third, 77% of local ATAC-QTLs-peaks were in intronic or intergenic regions ( fig.   S6A ); of these, 70% lie in regions that were previously identified as enhancers for different Th cell subtypes ( fig. S6B) . Fourth, ATAC-QTL-peaks were enriched for motifs bound by TFs involved in T cell development and activation (e.g., BATF, AP1 and IRF, Fig. 2E ) as compared to all ATAC-peaks detected in activated cells as background. In fact, 57% of ATAC-QTL-peaks contained either a BATF or an ETS1 motif (a 1.2 fold enrichment compared to all ATAC-peaks in activated cells, P < 1.79×10 -19 , hypergeometric test; with all peaks as background) and 11% contained both (an 1.3-fold enrichment, P < 4.02×10 -5 , hypergeometric test). Furthermore, ATAC-QTL-peaks overlapping BATF, ETS1 and CTCF binding sites showed differential accessibility between genotypes at single nucleotide resolution, with the core motif exhibiting the most striking difference in accessibility ( Fig. 2F and fig. S7 ). This effect extended 1 kb outside the core binding motif, demonstrating that genetic variants may not only cause differential transcription factor binding, but also give rise to long-range effects on chromatin accessibility ( Fig. 2F and fig. S8) . Similarly, the effect size of ATAC-QTLs is correlated with SNP motif disruption scores obtained by deltaSVM (30) , an unbiased analysis to discover de novo cis-regulatory elements in ATAC peaks ( Fig. 2G, SOM) . Most (61%) of the ATAC-QTL lead SNPs strongly disrupted one of 11 predicted TF binding sites (TFBSs) (Fig. 2H) . These 11 predicted TFBS, which arose automatically from this analysis, included many known to act in T cell activation, such as BATF, IRF, NFκB and ATF.
Local ATAC-QTLs were also enriched for GWAS SNPs from autoimmune diseases ( Fig. 2I) , providing a functional context for interpreting these disease associations. For example, rs17293632, an ATAC-QTL SNP, has also been associated with Crohn's disease and IBD in GWAS studies. This SNP is located in the first intron of SMAD3, a TF gene involved in the TGF-β signaling pathway that regulates T cell activation and metabolism (33) . This SNP disrupts a consensus BATF binding site at a conserved position (deltaSVM=-12.72), and results in decreased chromatin accessibility in individuals that possess the alternate allele ( Fig. 2J) .
Rs17293632 was also identified as a causal variant by a statistical fine-mapping algorithm that leveraged patterns of linkage disequilibrium but is agnostic to the functional genomic data in this region (16) . This suggests that rs17293632 may increase susceptibility to Crohn's disease and IBD by disrupting BATF binding at the SMAD3 locus.
As noted above, we found substantial correlation in accessibility between 1,762 pairs of ATACpeaks. We next tested the hypothesis that correlated ATAC-peaks could be simultaneously modulated by a single SNP, thereby allowing a single variant to influence multiple cis-regulatory regions. Specifically, we found that both local and moderately distal ATAC-QTLs (< 1 Mb) are more strongly associated with correlated peaks than to single peaks (defined as any ATAC-peak that is not part of a correlated peak pair; Fig. 3A, fig. S8 ). Furthermore, correlated peaks that were associated with ATAC-QTLs were more strongly correlated with each other than correlated peaks that were not associated with an ATAC-QTL ( Fig. 3B and table S2 ). This suggests that genetic variants could impart stronger co-regulation of cis-regulatory regions than epigenetic mechanisms. For example, rs10815868, an ATAC-QTLs associated with a pair of correlated peaks, resides in the 18th intron of PTPRD, a tumor suppressor gene, where it disrupts a consensus BATF binding site at a conserved position. This ATAC-QTL is associated with decreased chromatin accessibility in a 4 kb region that contains four highly correlated ATACpeaks ( Fig. 3C , yellow box). Notably, an adjacent peak located 5 kb upstream of this region was not affected by this variant (Fig. 3C , grey box), suggesting that the genetic control of multiple ATAC-peaks was limited to a defined regulatory region.
To test if the relationship between correlated peaks could be influenced by the 3D conformation of the Th cell chromatin, we performed loop-resolution in situ Hi-C (34) in primary CD4 + T cells activated for 48 hr. We obtained Hi-C maps at 50 kb resolution and identified 4,614 contact domains (internals of chromatin in which all loci exhibit an enhanced frequency of contact with one another) and 4,419 chromatin loops (pairs of loci that are in closer physical proximity to one another than to neighboring sequences on the chromosome, such as the interaction between a promoter and its distal enhancer) ( fig. S9 and table S4 ). ATAC-peaks overlapping BATF and ETS1 motifs were enriched within Hi-C contact domains ( Fig. 3D) , whereas those overlapping CTCF motifs were enriched at the contact domain boundaries ( Fig. 3D and fig. S10A ). This is consistent with previous reports of CTCF enrichment at loop anchors and at contact domain boundaries (34) (35) (36) (37) .
There was a clear relationship between the 3D structure of chromatin, the correlated peaks, and the associated ATAC-QTLs. Specifically, we found that correlated peaks were the most enriched when both peaks were in the same contact domain than when (i) both peaks lie outside of a contact domain, or (ii) only one of the two peaks was in a contact domain, or (iii) the two peaks span a contact domain ( Fig. 3E, fig. S10B ,C and table S4; considering all domains, SOM).
Moreover, correlated ATAC-QTL-peaks exhibited stronger genetic associations if both peaks resided in the same contact domain than if they did not ( Fig. 3F) . This suggests that 3D chromatin structure may explain the ability of a single genetic variant to influence multiple correlated ATAC-peaks.
Furthermore, correlated peaks -whether or not they were associated with an ATAC-QTL -were enriched in super-enhancer regions from CD4 + Th cell (38) (Super-enhancers, also called stretch enhancers, are defined as large clusters of contiguous enhancers (38, 39) .) ( Fig. 3G, table S2 and SOM). Correlated peaks with an associated ATAC-QTL were more enriched for superenhancers if they reside in the same contact domain (1.6-fold) ( Fig. 3G) . For example, rs2732588 is an ATAC-QTL associated with three correlated peaks. Individuals who are homozygous alternate at the variant [GàA] tend to exhibit decreased chromatin accessibility in a large 100 kb region containing multiple correlated ATAC-peaks ( Fig. 3H) . The affected region partially overlaps a previously identified super-enhancer in CD4 + T cells (38) . This superenhancer overlaps with both coding and intronic regions of KANSL1, a chromatin regulator that is part of the nonspecific lethal (NSL) complex controlling expression of constitutively expressed genes (40, 41) (Fig. 3H) . This region containing the super-enhancer and these correlated peaks was mostly contained inside a Hi-C contact domain, although it also extends immediately outside of the Hi-C contact domain boundary ( Fig. 3H) . Together, these data support a model in which the effects of a genetic variant on the accessibility of nearby loci is influenced by 3D proximity and that these effects are stronger when both the variant and the affected peaks lie in the same contact domain.
To further understand the consequences of ATAC-QTLs on gene regulation, we measured RNAseq profiles from activated CD4 + T cells from 96 donors (93 with matching ATAC-seq data), and mapped expression QTLs (eQTLs), genetic variants that affect gene expression ( Fig. 4) . We identified 816 genes with at least one significant local eQTL (+/-500 kb centered around the gene) (RASQUAL, P < 4.12×10 -5 , permutation FDR < 0.05) ( Fig. 4C, fig. S11, table S5) , termed eQTL-genes. The 816 eQTL-genes were enriched in HiC contact domains compared to all genes (437 genes intersecting contact domains, 6.6 fold enrichment, P < 3.44×10 -247 , hypergeometric test), suggesting that eQTL-genes are in regions of 3D chromatin interaction in T cells.
We assessed the mediation of genetic effects on gene expression through chromatin accessibility. 71 genetic variants, corresponding to 103 unique genes, were simultaneously the lead SNP for an eQTL and an ATAC-QTL with correlated effect sizes (Pearson rho = 0.52, Fig. 4A, table S6 ).
Because in-sample overlapping of eQTL and ATAC-QTLs has limited power to detect shared genetic variants, we used a feature selection prediction framework (43, 44) to detect associations between imputed ATAC-peaks and gene expression. For 1,790 significant ATAC-QTL-peaks, we identified 104 genes significantly associated with predicted local (+/-500 kb) ATAC-peak accessibility in 96 individuals (FDR < 0.05, 10 permutations, Fig. 4B,C, table S7 ), of which 67 were eQTL-genes. These results demonstrate how the inherent hierarchy in how genetic variants modulate chromatin state and gene expression enables the use of imputed chromatin accessibility to simultaneously identify genetically controlled genes and to annotate cis regulatory elements mediating the genetic effect.
For example, rs174556, an ATAC-QTL associated with a pair of correlated peaks, resides in a 25 kb region between two Hi-C contact domains, where the alternative allele disrupts a CTCF binding site ( Fig. 4D) . Rs174556 is linked (D'=1, R 2 =0.79) with rs102275, a variant previously associated with Crohn's disease (45) . The associated correlated peaks span the promoters of FADS1 and FADS2, two fatty acid desaturase (FADS) genes. Rs174556 is also identified as an eQTL for both FADS1 and FADS2 in our T cell dataset ( Fig. 4C) . FADS1 and FADS2 regulate inflammation, promote cancer development by regulating the metabolism of arachiodonic acid and its derivatives prostaglandin E2, and FADS2 knockout mice develop dermal and intestinal ulcerations (46) (47) (48) (49) . Given the well-known role of CTCF in maintaining the integrity of chromatin domain boundaries and insulation of transcriptional activities, abolishing CTCF binding may abolish the insulation, opening chromatin and causing increased expression of both target genes. These results suggest that variability in chromatin accessibility may underlie variability in gene expression and may increase disease risk.
In conclusion, we integrated genetic variation and ATAC-seq data from primary activated CD4 + T cells from 105 healthy donors to identify and characterize genetic variants that contribute to variability in chromatin accessibility. We found widespread genetic control of chromatin accessibility, some of which affected multiple ATAC-peaks in a manner consistent with the 3D organization of the genome. Integrating genotyping, ATAC-seq and RNA-seq data provided causal anchors for predicting and explaining the variability in molecular traits in a manner consistent with known modes of transcriptional regulation. We did not find significant distal effects, consistent with reports that measured chromatin state by DNAse-I-seq (17), but unlike studies that measured chromatin state using ChIP-seq (18) (19) (20) . Predicting variability in gene expression between individuals based on chromatin state is significantly impacted by technical and biological variability in the assays, but is helped by leveraging genetic variation as causal anchors. It is possible that our ability to detect weaker interactions and predict gene expression could significantly improve with increased sample sizes and deeper sequencing.
Our findings, derived from large scale mapping of epigenetic quantitative traits in primary human cells implicated in many diseases, provide a molecular framework for the interpretation of disease-causing variants, focused on modeling how genetic variants could alter local chromatin structure to modulate gene expression. Future studies that use other disease-relevant primary cells and tissues will help pinpoint causal disease variants and understand the regulatory mechanism underlying common disease.
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Study subjects and genotyping
Healthy subjects between the ages of 18 to 56 (avg. 29.9) enrolled in the PhenoGenetic study (8) were recruited from the Greater Boston Area and gave written informed consent for the studies.
Individuals were excluded if they had a history of inflammatory disease, autoimmune disease, chronic metabolic disorders or chronic infectious disorders. Genotyping demographics of the donors are listed in table S8. Genotyping using the Illumina Infinium Human OmniExpress Exome BeadChips (704,808 SNPs are common variants [MAF > 0.01] and 246,229 are part of the exomes, respectively; Illumina Inc., San Diego, CA) has been previously described (16) . The genotype success rate was at least 97%. We applied rigorous subject and SNP quality control (QC) that includes: (1) gender misidentification; (2) subject relatedness; (3) Hardy-Weinberg Equilibrium testing; (4) use concordance to infer SNP quality; (5) genotype call rate; (6) heterozygosity outlier; and (7) subject mismatches. We excluded 1,987 SNPs with a call rate < 95%, 459 SNPs with Hardy-Weinberg equilibrium p-value < 10 -6 , and 63,781 SNPs with MAF < 1% from the 704,808 common SNPs (a total of 66,461 SNPs excluded).
We used the IMPUTE2 software (version: 2.3.2) to impute the post-QC genotyped markers from the entire Immvar cohort (N = 688) using reference haplotype panels from the 1000 Genomes Project (The 1000 Genomes Project Consortium Phase III) that contain a total of 37.9 Million SNPs in 2,504 individuals with ancestry from West Africa, East Asia, and Europe. After genotype imputation, we extracted the genotypes for 108 individuals assayed for chromatin accessibility and gene expression. Additional filtering for SNPs with MAF < 0. 1 in our cohort, resulted in 4,558,693 and 4,421,936 common variants tested for chromatin accessibility and gene expression assays, respectively.
Preparation and activation of primary human CD4 + T cells
CD4 + T cells were isolated and stimulated as previously described (10) . Briefly, CD4 + T cells were isolated from whole blood by negative selection using RosetteSep human CD4 + T cell enrichment cocktail (STEMCELL Technologies Inc., Vancouver, BC) and RosetteSep density medium gradient centrifugation. Isolated CD4 + T cells were placed in freezing container at -80°C for overnight, and then moved into a liquid nitrogen tank for long-term storage. On the day of activation, CD4 + T cells were thawed in a 37°C water bath, counted and resuspended in RPMI- 
ATAC-seq profiling
ATAC-seq profiles were collected for 139 individuals (table S8). We performed ATAC-seq as previously described (21) , with a modification in the lysis buffer to reduce mitochondrial DNA contamination, while maintaining high complexity of nuclear reads. 200,000 purified CD4 + T cells were lysed with cold lysis buffer (10 mM Tris-HCl, pH 7.4, 10 mM NaCl, 3 mM MgCl 2 and 0.03% tween20). Immediately after lysis, nuclei were spun at 500g for 8 minutes at 4°C.
After pelleting the nuclei, we carefully removed the supernatant and resuspended the nuclei with Tn5 transposase reaction mix (25 ul 2X TD buffer, 2.5 ul Tn5 transposase, and 22.5 ul nucleasefree water) (Illumina Inc). The transposition reaction was performed at 37°C for 30 minutes.
Immediately after the transposition reaction, DNA was purified using a Qiagen MinElute kit.
Libraries were sequenced on an Illumina HiSeq 2500 sequencer to an average read depth of 42 million (+/-38 million) per sample ( fig. S2) , with low mtDNA contamination (0.30%-5.39%, 1.96% on average), low rates of multiply mapped reads (6.7%-56%, 19% on average) and a relatively high proportion of usable nuclear reads (60%-92%, 79% on average).
RNA-seq profiling
RNA-seq profiles were collected for 95 individuals, of which 93 have matching ATAC-seq profiles (table S8). RNA was isolated using Qiagen RNeasy Plus Mini Kit and RNA integrity was quantified by Agilent RNA 6000 Nano Kit using the Agilent Bioanalyzer. Purified RNA were converted to RNA-seq libraries using a previously published protocol (50), where reverse transcription was carried out based on the SMART template switching method and the resulting cDNA was further tagmented and PCR amplified using Nextera XT DNA Sample kit (Illumina) to add the Illumina sequencing adaptors. Samples were sequenced on Illumina HiSeq 2500 to an average depth of 16.9 million reads per sample (+/-8.7 million).
In situ-Hi-C
CD4 + T cells were isolated from commercially available fresh blood of healthy individuals (Research Blood Components). CD4 + T cells were stimulated for 48 hours with beads conjugated with anti-CD3 and anti-CD28 antibodies and then crosslinked with 1% formaldehyde for 10 min at room temperature. In situ-Hi-C was performed as previously described (34) . Libraries were sequenced using Illumina HiSeq and NextSeq, to produce ~1 billion 100bp paired-end reads.
Alignment of ATAC-seq reads
25bp ATAC-seq reads were aligned to the human genome assembly (hg19) with the Burrows Wheeler Aligner-MEM (version: 0.7.12) (51). For each sample, mitochondrial reads and multiply-mapped reads were filtered out using BEDtools (function intersectBed) (52) . After filtering, we had an average of 42 million (+/-38 million) reads per sample.
ATAC-seq peak identification
Filtered ATAC-seq reads from matched unstimulated and activated CD4 + T cell ATAC-seq reads from 6 individuals were merged (separately for unstimulated and for activated cells) using the Samtools function "merge". Peaks were called on the unstimulated CD4 + T cell merged bam file and the activated CD4 + T cell merged bam file using MACS2 -callpeak (with parameters -nomodel, --extsize 200, and --shift 100), such that there were 36,486 unstimulated peaks with an average width of 520 bp (+/-319 bp) and 52,154 activated CD4 + T cell peaks with an average width of 483 bp (+/-344 bp) (Benjamini-Hochberg FDR < 0.05). The activated and unstimulated CD4 + T cell peaks were further merged (using the BEDtools "merge" function), to a total of 63,763 jointly called peaks. A matrix of the coverage for each of the 63,763 peaks in each of the 12 samples was used as input for calling differential peaks. Differential peaks between activated and unstimulated conditions were identified using the DESeq2 R package (version 3.2) (53), with 8,298 regions more accessible in unstimulated CD4 + T cells, and 28,017 regions more accessible in activated CD4 + T cells (FDR < 0.05).
Enrichment of transcription factor binding motifs
We used the Homer suite (52) , which uses ChIP-seq data from the ENCODE (25) and
Epigenomics Roadmap (15) projects, to determine transcription factor enrichment within our ATAC-peaks, using the findMotifsGenome.pl (with parameters hg19 and -size given). For the analysis in Fig. 2E , we used an additional parameter -bg, using the activated CD4 + T cell peaks as background, instead of the local background generated by HOMER. This allowed us to determine which transcription factors were more enriched in our ATAC-QTLs than all background ATAC-peaks.
Outlier and sample mix-up analysis
Using the software VerifyBamID (54), we matched each ATAC-seq and RNA-seq sample with each genotyping array. Samples were identified as those with the highest fIBD, and those with designated labels not matching the VerifyBamID predicted labels were flagged as sample mixups. We switched the designated label to the predicted label for cases where the fIBD > 90%. 15 out of the 139 total ATAC-seq samples were re-labeled and 4 out of the 110 total RNA-seq samples were re-labeled. For the ATAC-seq samples: 18 do not have genotypes, 3 are outliers, 1 did not match anyone. For the 110 RNA-seq samples: 8 samples do not have genotypes, 5 are outliers, 1 did not match anyone. 111 ATAC-seq samples and 96 RNA-seq samples were used in the final analysis after filtering for outliers (average mean correlation to others samples < 0.7). In the pilot study, there were 5 people total, 1 person was repeated for a total of 6 samples, none were genotyped.
Mapping of ATAC-QTLs
We mapped local ATAC-QTLs by running RASQUAL (29) on the 52,154 peaks identified in activated CD4 + T cells and 4,558,693 imputed genetic variants, testing variants within a 40-kb window of each ATAC-peak, and filtering for a minor allele frequency of 10% to remove rare variants. The input to RASQUAL is the number of reads in each peak quantified using BEDtools "coverage" with using uniquely mapped nuclear reads for each individual. Duplicated fragments were kept for quantification. Date and time of visit, sex, age, race, ethnicity, height, weight, BMI, blood pressure, sequencing batch, and preparation batch were removed as covariates, along with four principal components to minimize confounding factors. Using the RASQUAL "-r" option, 10 random permutations for each feature were generated. Then, the empirical null distributions and P-values were compared using the R qvalue (55) package, for a total of 1,790 local ATAC-QTLs at a FDR of 0.1. Distal ATAC-QTLs were similarly mapped at a window of > 40-kb but < 1 Mb to attain a total of 7,301 distal ATAC-QTLs.
Hi-C data analysis
Data were processed using a custom pipeline that uses BWA (51) to map each read separately and Hi-C contact domains and chromatin loops were identified as previously described (34) .
Determination of distance from ATAC-seq peak to contact domains
We determined the distance from each feature of interest to the middle of the closest contact domain. We analyzed the following features: (1) ATAC-peaks; (2) ATAC-peaks containing a significant genetic association ("ATAC-QTL-peaks"); ATAC-peaks containing (3) BATF, (4) ETS1, or (5) CTCF motifs; and ATAC-QTL-peaks containing (6) BATF, (7) ETS1, or (8) CTCF motifs. We normalized the distances from each feature to the closest domain by the length of the domain. In order to determine that the distribution of the distance between a given feature and a contact domain is different than the null distribution, we kept the length of each contact domain constant and shuffled the positions of the contact domain. The distances from the feature to the contact domain were binned into 30 bins and divided by the binned distances between a given feature and the shuffled contact domains to determine enrichment at each position.
Correlated peak analysis
To identify correlated peaks, we tested for correlation between every pair of the 52,154 ATACpeaks within 1.5 Mb of each other using a linear regression in Matrix eQTL (56) . To correlate peaks, we first normalized the ATAC-peaks by (1) removing sequencing depth bias using a median normalization, (2) standardizing the matrix by subtracting out the mean and dividing by the standard deviation; and (3) quantile normalizion of the matrix (Bolstad BM (2016).
preprocessCore: A collection of pre-processing functions. R package version 1.34.0, https://github.com/bmbolstad/preprocessCore). Next, we removed covariates (as described for mapping of ATAC-QTLs) and three principal components. Then, we identified 851/1,762 correlated peaks (387 unique ATAC-peaks) with ATAC-QTLs (FDR < 0.05 ), of which 159 correlated peaks (93 unique ATAC-peaks) with ATAC-QTLs reside in contact domains. To ensure that the correlated peaks were enriched in contact domains, we again permuted the position of the contact domains while keeping the length of the contact domains constant and performed the same analysis ( fig. S10) .
RNA-seq analysis
25bp paired end RNA-seq reads were aligned to the hg19 using UCSC transcriptome annotations. Expression levels (expected counts) were determined using RSEM (57) . We applied TMM normalization to the expected counts using the edgeR package and filtered for genes that had TMM count > 1 in at least 75% of the samples. For the mapping of eQTLs, we inputted raw counts for filtered genes into RASQUAL which performs internal normalization. For the repeatability, heritability and predictability analyses, we used log transformed TMM counts of filtered genes in order to fit generalized linear models. eQTL fine-mapping RASQUAL (29) was used to map eQTLs within a 1 Mb window of a gene, using gene expression levels (TPM) from RSEM and genotypes filtered as above for a minor allele frequency of 0.1. To minimize confounding factors, 16 principal components, date and time of visit, sex, age, race, ethnicity, height, weight, BMI, blood pressure, sequencing batch, and preparation batch were removed as covariates. The RASQUAL "-r" option was used for permutations to determine the empirical null distribution and compute a FDR, retaining 816 eQTLs at FDR<0.05.
GWAS enrichment
The GREGOR suite was used for calculating the enrichment of loci from GWAS in features of interest (56): (1) peaks differentially accessible in activated CD4+ T cells; (2) peaks differentially accessible in unstimulated CD4+ T cell peaks, and (3) peaks shared in both conditions. The 95% confidence interval was calculated from the log 10 (odds ratio), where the odds ratio was the number of GWAS overlaps / expected overlaps.
Overlap of traits in genomic regions
The Homer suite tool annotatePeaks.pl was used to determine the number of quantitative traits intersecting each genomic feature of interest. For enhancers, we specified the -ann parameter for the T cell H3K27ac enhancer annotation (16) .
Enrichment in Super-enhancer regions
Using the BEDtools intersect function, we calculated how many of the correlated peaks, genetically-associated correlated peaks, and genetically-associated correlated peaks that fall in contact domains are also in stimulated T helper super-enhancers (as reported in Hinsz et al (38) ).
To calculate an enrichment score, for each pair of correlated peaks, we fixed one peak and mirrored the second peak by the peak distance to preserve the genomic properties of the correlated peak, while breaking any correlation to annotated enhancers. To calculate a confidence interval for the enrichment score, we shuffled the position of super-enhancers, while maintaining the length of the super-enhancer 10 times and calculated the enrichment score of intersected features to the mirrored features with the shuffled super-enhancers.
Gkm-SVM and deltaSVM
We ran gkm-SVM (31, 32) on 24,745 300bp ATAC-peaks centered on MACS summits using default parameters and an equal size GC matched negative set, excluding from training any region containing a SNP to be scored by deltaSVM, and repeated with 5 independent negative sets, and averaged the deltaSVM predictions, as previously described (30) . We then calculated deltaSVM for each SNP within 200bp of the peak signal of an ATAC-QTL with peak p-value < 10 -5 , scoring 663 SNPs in 500 loci. We find a Pearson correlation of C=0.611 between ATAC-QTL beta and the largest deltaSVM SNP. 442 of the peak p-value SNPs had the largest deltaSVM, but 58 flanking SNPs scored more highly than the peak p-value SNP and disrupt immune associated TF binding sites. While the gkm-SVM weights fully specify the deltaSVM score, for interpretation we associated the large gkm-SVM weights with the most similar TF PWM from a catalog of JASPAR, Transfac, Uniprobe, and Homer motifs.
Heritability and prediction of gene expression and ATAC-peaks
Data for predictability and heritability analysis of gene expression and ATAC-peaks was prepared in following way. Each ATAC-peak was residualized against its 4 principal components and patient data covariates (date and time of visit, sex, age, height, weight, systolic and diastolic blood pressure) for cross-validated prediction studies, or were included as fixed effects for the heritability analysis. Analogously, we used 16 principal components in the analyses of heritability and predictability of gene expression.
Repeatability was calculated by leveraging repeated measures of gene expression in 25
individuals whose cells were sampled on two different dates two years apart. Elastic net model prediction analysis was performed using glmnet R package with the L1 ratio set to 0.5 with 5fold cross-validation. For joint prediction of gene expression, we chose distinct weights for ATAC-peak and genotype features using a grid search approach (parameter grid 2^-3 to 2^3) to maximize the mean cross-validation R 2 . Reported R 2 estimates are calculated as in Gamazon et al. (43) . Restricted maximum likelihood heritability (h 2 ) estimates were calculated using GCTA software (58) with algorithm 0 and no constraints on heritability (i.e. h 2 can be less than 0). For the gene expression predictability analysis, we used genotype and ATAC-peak features +/-500 kb from the transcription start site of the gene. For the heritability and predictability analysis of ATAC-peaks, we used genotypes +/-500 kb and +/-20 kb from the center of each ATAC-peak respectively.
Association of gene expression to genetically imputed ATAC-peaks
In order to assess the ability to predict gene expression from genotypes mediated by ATACpeaks, we associated gene expression to imputed intensities of ATAC-peaks, similar to the approach proposed by Gamazon et al (43) . First, we split the available dataset into a training set and a test set of equal size (2 x 46). We used the training set to estimate the effect of genetic variants on ATAC-peaks using ordinary linear regression. Next, we applied the estimated effects to the test set to predict the intensity of ATAC-peaks. We correlated the imputed ATAC-peaks with gene expression and report the mean R 2 statistic for each gene from the analysis of three random partitions of training and test sets. We derived empirical p-value and FDR estimates on the R 2 statistic by shuffling the gene expression matrix 10 times. These results are compared to those obtained from associating genotype data with gene expression in the full cohort of 92. 
Figure legends
